← Back to search
4d0m

Phosphatidylinositol 4-kinase III beta in a complex with Rab11a-GTP- gamma-S and the Rab-binding domain of FIP3

Method: X-RAY DIFFRACTION Dmax: 206.1 Å Quality: REASONABLE
▼

1. Protein Identity and Related Structures Protein Identity & Related Structures

PHOSPHATIDYLINOSITOL 4-KINASE BETA

HOMO SAPIENS

UniProt Q9UBF8

State in the Current Structure

Assembly Oligomeric State Construct Mutations and Modifications Ligands, Ions and Associated Components Method and Experimental Conditions Structure Quality
1 Protein heterocomplex Heteromer Protein × 12 PDB declaration: dodecameric（12） Consistent with protein copy count Chain A； UniProt 121–303 Chain A； UniProt 319–421 Chain A； UniProt 522–799 Chain C； UniProt 121–303 Chain C； UniProt 319–421 Chain C； UniProt 522–799 Chain O； UniProt 121–303 Chain O； UniProt 319–421 Chain O； UniProt 522–799 Chain S； UniProt 121–303 Chain S； UniProt 319–421 Chain S； UniProt 522–799 Mutation：YES RAS-RELATED PROTEIN RAB-11A × 4 （P62491） RAB11 FAMILY-INTERACTING PROTEIN 3 × 4 （O75154） 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4 MG MAGNESIUM ION × 4 X-RAY DIFFRACTION X-ray crystallization conditions：16% PEG 6K, 0.01 M NA CITRATE Resolution 6.00 Å R-free 0.359
2 Protein heterocomplex Heteromer Protein × 12 PDB declaration: dodecameric（12） Consistent with protein copy count Chain G； UniProt 121–303 Chain G； UniProt 319–421 Chain G； UniProt 522–799 Chain I； UniProt 121–303 Chain I； UniProt 319–421 Chain I； UniProt 522–799 Chain M； UniProt 121–303 Chain M； UniProt 319–421 Chain M； UniProt 522–799 Chain Q； UniProt 121–303 Chain Q； UniProt 319–421 Chain Q； UniProt 522–799 Mutation：YES RAS-RELATED PROTEIN RAB-11A × 4 （P62491） RAB11 FAMILY-INTERACTING PROTEIN 3 × 4 （O75154） 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4 MG MAGNESIUM ION × 4 X-RAY DIFFRACTION X-ray crystallization conditions：16% PEG 6K, 0.01 M NA CITRATE Resolution 6.00 Å R-free 0.359
3 Protein heterocomplex Heteromer Protein × 12 PDB declaration: dodecameric（12） Consistent with protein copy count Chain W； UniProt 121–303 Chain W； UniProt 319–421 Chain W； UniProt 522–799 Chain Y； UniProt 121–303 Chain Y； UniProt 319–421 Chain Y； UniProt 522–799 Chain c； UniProt 121–303 Chain c； UniProt 319–421 Chain c； UniProt 522–799 Chain g； UniProt 121–303 Chain g； UniProt 319–421 Chain g； UniProt 522–799 Mutation：YES RAS-RELATED PROTEIN RAB-11A × 4 （P62491） RAB11 FAMILY-INTERACTING PROTEIN 3 × 4 （O75154） 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4 MG MAGNESIUM ION × 4 X-RAY DIFFRACTION X-ray crystallization conditions：16% PEG 6K, 0.01 M NA CITRATE Resolution 6.00 Å R-free 0.359

Other States of the Same Protein in the Database

Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.

Other PDB Difference from Current Entry 4D0M Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Method and Experimental Conditions Structure Quality
4D0L Phosphatidylinositol 4-kinase III beta-PIK93 in a complex with Rab11a- GTP gammaS Deposited 2014-04-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain A 121–407（287 aa） Fragment：RESIDUES 121-407,508-784
Chain A 508–784（277 aa） Fragment：RESIDUES 121-407,508-784
Mutation：YES Mutation：YES 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；15% (W/V) PEG 4000, 0.1 M NA CITRATE PH 5.6, AND 0.2 M AMMONIUM ACETATE
Resolution 2.94 Å R-free 0.259
4D0L Phosphatidylinositol 4-kinase III beta-PIK93 in a complex with Rab11a- GTP gammaS Deposited 2014-04-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain C 121–407（287 aa） Fragment：RESIDUES 121-407,508-784
Chain C 508–784（277 aa） Fragment：RESIDUES 121-407,508-784
Mutation：YES Mutation：YES 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；15% (W/V) PEG 4000, 0.1 M NA CITRATE PH 5.6, AND 0.2 M AMMONIUM ACETATE
Resolution 2.94 Å R-free 0.259
4D0L Phosphatidylinositol 4-kinase III beta-PIK93 in a complex with Rab11a- GTP gammaS Deposited 2014-04-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain E 121–407（287 aa） Fragment：RESIDUES 121-407,508-784
Chain E 508–784（277 aa） Fragment：RESIDUES 121-407,508-784
Mutation：YES Mutation：YES 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；15% (W/V) PEG 4000, 0.1 M NA CITRATE PH 5.6, AND 0.2 M AMMONIUM ACETATE
Resolution 2.94 Å R-free 0.259
4WAE Phosphatidylinositol 4-kinase III beta crystallized with ATP Deposited 2014-08-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 128–422（295 aa） Fragment：UNP residues 130-422, UNP residues 523-799
Chain A 523–799（277 aa） Fragment：UNP residues 130-422, UNP residues 523-799
Not recorded ATP ADENOSINE-5'-TRIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；293 K；10% w/v PEG 4000, 20% v/v glycerol 0.1 M MOPS/HEPES-Na pH 7.5
Resolution 3.32 Å R-free 0.244
4WAG Phosphatidylinositol 4-kinase III beta crystallized with MI103 inhibitor Deposited 2014-08-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 128–422（295 aa） Fragment：UNP residues 128-422, UNP residues 523-799
Chain A 523–799（277 aa） Fragment：UNP residues 128-422, UNP residues 523-799
Not recorded 3K7 6-chloro-3-(3,4-dimethoxyphenyl)-2-methylimidazo[1,2-b]pyridazin-8-amine × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；293 K；10% w/v PEG 4000, 20% v/v glycerol 0.1 M MOPS/HEPES-Na pH 7.5
Resolution 3.41 Å R-free 0.251
5C46 Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta in complex with GTP gamma S loaded Rab11 Deposited 2015-06-17 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain E 121–248（128 aa）
Chain E 288–407（120 aa）
Chain E 508–784（277 aa）
Mutation：S294A Mutation：S294A Mutation：S294A SO4 SULFATE ION × 2 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 5.6；290 K；PEG-4000, sodium citrate, ammonium sulfate, glycerol
Resolution 2.65 Å R-free 0.246
5C4G Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta with the inhibitor BQR695 in complex with GDP loaded Rab11 Deposited 2015-06-18 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain E 121–248（128 aa）
Chain E 288–407（120 aa）
Chain E 508–784（277 aa）
Mutation：S294A Mutation：S294A Mutation：S294A MG MAGNESIUM ION × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 SO4 SULFATE ION × 2 BQR N~2~-[7-(3,4-dimethoxyphenyl)quinoxalin-2-yl]-N-methylglycinamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 5.6；290 K；PEG-4000, sodium citrate, ammonium sulfate, glycerol
Resolution 3.20 Å R-free 0.287
5EUQ Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta with a potent and selective inhibitor in complex with GDP loaded Rab11 Deposited 2015-11-19 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Insufficient information Heteromer；Protein × 2 PDB declaration: dimeric
Chain E 121–248（128 aa）
Chain E 523–799（277 aa）
Mutation：S294A Mutation：S294A GDP GUANOSINE-5'-DIPHOSPHATE × 1 SO4 SULFATE ION × 2 5S8 ~{N}-[5-[3-[[(4-hydroxyphenyl)amino]-bis(oxidanyl)-$l^{4}-sulfanyl]-4-methoxy-phenyl]-4-methyl-1,3-thiazol-2-yl]cyclopentanecarboxamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION；pH 5.6；290 K；PEG-4000, sodium citrate, ammonium sulfate, glycerol
Resolution 3.20 Å R-free 0.266
5FBL PI4KB in complex with Rab11 and the MI356 Inhibitor Deposited 2015-12-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain A 128–422（295 aa） Fragment：UNP Residues 128-422, 523-799
Chain A 523–799（277 aa） Fragment：UNP Residues 128-422, 523-799
Not recorded 5W9 ~{N}-[2-[[6-chloranyl-3-(4-methoxy-3-morpholin-4-ylsulfonyl-phenyl)-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；291 K；1M Lithium chloride, 0.1M Citric acid pH=5, 10% (w/v) PEG 6000
Resolution 3.37 Å R-free 0.269
5FBQ PI4KB in complex with Rab11 and the MI358 Inhibitor Deposited 2015-12-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain A 128–422（295 aa） Fragment：UNP Residues 128-422, 523-799
Chain A 523–799（277 aa） Fragment：UNP Residues 128-422, 523-799
Not recorded 5W6 ~{N}-[2-[[6-chloranyl-3-[3-[4-(hydroxymethyl)piperidin-1-yl]sulfonyl-4-methoxy-phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；291 K；0.2M magnesium chloride, 0.1M Tris PH=7, 10% (w/v) PEG 8000
Resolution 3.79 Å R-free 0.302
5FBR PI4KB in complex with Rab11 and the MI359 Inhibitor Deposited 2015-12-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain A 128–422（295 aa） Fragment：UNP Residues 128-422, 523-799
Chain A 523–799（277 aa） Fragment：UNP Residues 128-422, 523-799
Not recorded 5W7 ~{N}-[2-[[3-[3-[(4-azanylcyclohexyl)sulfamoyl]-4-methoxy-phenyl]-6-chloranyl-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；291 K；0.15M amonium sulfate, 0.1M MES pH=6, 15% PEG 4000
Resolution 3.28 Å R-free 0.264
5FBV PI4KB in complex with Rab11 and the MI364 Inhibitor Deposited 2015-12-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain A 128–422（295 aa） Fragment：UNP Residues 128-422, 523-799
Chain A 523–799（277 aa） Fragment：UNP Residues 128-422, 523-799
Not recorded 5W3 ~{N}-[2-[[6-chloranyl-3-[3-(2-hydroxyethylsulfamoyl)-4-methoxy-phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethy l]ethanamide × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；291 K；0.15M amonium sulfate, 0.1M MEW pH=6, 15% PEG 4000
Resolution 3.29 Å R-free 0.281
5FBW PI4KB in complex with Rab11 and the MI369 Inhibitor Deposited 2015-12-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain A 128–422（295 aa） Fragment：UNP Residues 128-422, 523-729,UNP Residues 128-422, 523-729
Chain A 191–467（277 aa） Fragment：UNP Residues 128-422, 523-729,UNP Residues 128-422, 523-729
Not recorded 5W8 ~{N}-[2-[[6-chloranyl-3-[4-methoxy-3-[[(2~{R})-1-oxidanylbutan-2-yl]sulfamoyl]phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；291 K；0.2M ammonium sulfate, 0.1M MES pH=6.5, 20% (w/v) PEG 8000
Resolution 3.49 Å R-free 0.283
5NAS Crystal structure of human 14-3-3 zeta in complex with PI4KIIIB peptide Deposited 2017-02-28 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain C 289–297（9 aa） Fragment：UNP residues 289-297
Chain D 289–297（9 aa） Fragment：UNP residues 289-297
Non-standard monomer：Yes (specific site not provided by mmCIF) Non-standard monomer：Yes (specific site not provided by mmCIF) No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；291 K；MES, PEG, ethylene glycol
Resolution 2.08 Å R-free 0.231
6GL3 Crystal structure of human Phosphatidylinositol 4-kinase III beta (PI4KIIIbeta) in complex with ligand 44 Deposited 2018-05-22 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 317–428（112 aa）
Chain A 532–798（267 aa）
Not recorded EMW (3~{S})-4-(6-azanyl-1-methyl-pyrazolo[3,4-d]pyrimidin-4-yl)-~{N}-(4-methoxy-2-methyl-phenyl)-3-methyl-piperazine-1-carboxamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；293 K；0.2 M sodium citrate, 22% (w/v) PEG3350, 10 mM Manganese(II)chloride
Resolution 2.77 Å R-free 0.333
6GL3 Crystal structure of human Phosphatidylinositol 4-kinase III beta (PI4KIIIbeta) in complex with ligand 44 Deposited 2018-05-22 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 317–428（112 aa）
Chain B 532–798（267 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；293 K；0.2 M sodium citrate, 22% (w/v) PEG3350, 10 mM Manganese(II)chloride
Resolution 2.77 Å R-free 0.333
8Q6F HUMAN PI4KIIIB IN COMPLEX WITH COVALENTLY BOUND INHIBITOR (COMPOUND 4) Deposited 2023-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric
Chain A 291–415（125 aa）
Mutation：R409Q,R412Q KHR 3-(3-fluorosulfonyloxy-4-methoxy-phenyl)-2,5-dimethyl-7-(pyridin-4-ylmethylamino)pyrazolo[1,5-a]pyrimidine × 1 MG MAGNESIUM ION × 1 EDO 1,2-ETHANEDIOL × 7 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293 K；Sodium Formate
Resolution 1.51 Å R-free 0.224
8Q6G HUMAN PI4KIIIB IN COMPLEX WITH COVALENTLY BOUND INHIBITOR (COMPOUND 8) Deposited 2023-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric
Chain A 291–415（125 aa）
Mutation：R409Q,R412Q KIH 3-(3,4-dimethoxyphenyl)-7-[(4-fluorosulfonyloxyphenyl)methylamino]-2,5-dimethyl-pyrazolo[1,5-a]pyrimidine × 1 MG MAGNESIUM ION × 1 EDO 1,2-ETHANEDIOL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293 K；Sodium Formate
Resolution 1.54 Å R-free 0.221
8Q6H HUMAN PI4KIIIB IN COMPLEX WITH COVALENTLY BOUND INHIBITOR (COMPOUND 11) Deposited 2023-08-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Insufficient information Monomer；Protein × 1 PDB declaration: monomeric
Chain A 291–415（125 aa）
Mutation：R409Q,R412Q MG MAGNESIUM ION × 1 KI7 3-(3-fluorosulfonyloxy-4-methoxy-phenyl)-7-[(4-fluorosulfonyloxyphenyl)methylamino]-2,5-dimethyl-pyrazolo[1,5-a]pyrimidine × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293 K；Sodium Formate
Resolution 1.94 Å R-free 0.237
8VOF GI targeted CpPI4K inhibitor Deposited 2024-01-15 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain A 121–407（287 aa）
Mutation：L294A,L374Y,P597Y A1ADE methyl 2-chloro-5-(methyl{(8R)-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carbonyl}amino)benzoate × 1 SO4 SULFATE ION × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；294 K；0.5M ammonium sulfate, 0.088M sodium citrate, 0.875M lithium sulfate, 2.4% glycerol, 2.5% ethylene glycol, 50mM HEPES pH 6.8
Resolution 3.00 Å R-free 0.270

17 other PDB entries and 20 assemblies. Open the comparison page and filter oligomeric states

View Construct and Data Evidence
UniProt name PI4KB_HUMAN
Isoform —
PDB entities 1
Chains and sequence ranges Author chain A； PDBConstruct 3–185； UniProt 121–303 Author chain A； PDBConstruct 186–288； UniProt 319–421 Author chain A； PDBConstruct 289–566； UniProt 522–799 Author chain C； PDBConstruct 3–185； UniProt 121–303 Author chain C； PDBConstruct 186–288； UniProt 319–421 Author chain C； PDBConstruct 289–566； UniProt 522–799 Author chain G； PDBConstruct 3–185； UniProt 121–303 Author chain G； PDBConstruct 186–288； UniProt 319–421 Author chain G； PDBConstruct 289–566； UniProt 522–799 Author chain I； PDBConstruct 3–185； UniProt 121–303 Author chain I； PDBConstruct 186–288； UniProt 319–421 Author chain I； PDBConstruct 289–566； UniProt 522–799 Author chain M； PDBConstruct 3–185； UniProt 121–303 Author chain M； PDBConstruct 186–288； UniProt 319–421 Author chain M； PDBConstruct 289–566； UniProt 522–799 Author chain O； PDBConstruct 3–185； UniProt 121–303 Author chain O； PDBConstruct 186–288； UniProt 319–421 Author chain O； PDBConstruct 289–566； UniProt 522–799 Author chain Q； PDBConstruct 3–185； UniProt 121–303 Author chain Q； PDBConstruct 186–288； UniProt 319–421 Author chain Q； PDBConstruct 289–566； UniProt 522–799 Author chain S； PDBConstruct 3–185； UniProt 121–303 Author chain S； PDBConstruct 186–288； UniProt 319–421 Author chain S； PDBConstruct 289–566； UniProt 522–799 Author chain W； PDBConstruct 3–185； UniProt 121–303 Author chain W； PDBConstruct 186–288； UniProt 319–421 Author chain W； PDBConstruct 289–566； UniProt 522–799 Author chain Y； PDBConstruct 3–185； UniProt 121–303 Author chain Y； PDBConstruct 186–288； UniProt 319–421 Author chain Y； PDBConstruct 289–566； UniProt 522–799 Author chain c； PDBConstruct 3–185； UniProt 121–303 Author chain c； PDBConstruct 186–288； UniProt 319–421 Author chain c； PDBConstruct 289–566； UniProt 522–799 Author chain g； PDBConstruct 3–185； UniProt 121–303 Author chain g； PDBConstruct 186–288； UniProt 319–421 Author chain g； PDBConstruct 289–566； UniProt 522–799

RAS-RELATED PROTEIN RAB-11A

HOMO SAPIENS

UniProt P62491

State in the Current Structure

Assembly Oligomeric State Construct Mutations and Modifications Ligands, Ions and Associated Components Method and Experimental Conditions Structure Quality
1 Protein heterocomplex Heteromer Protein × 12 PDB declaration: dodecameric（12） Consistent with protein copy count Chain B； UniProt 1–216 Chain D； UniProt 1–216 Chain P； UniProt 1–216 Chain T； UniProt 1–216 Mutation：YES PHOSPHATIDYLINOSITOL 4-KINASE BETA × 4 （Q9UBF8） RAB11 FAMILY-INTERACTING PROTEIN 3 × 4 （O75154） 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4 MG MAGNESIUM ION × 4 X-RAY DIFFRACTION X-ray crystallization conditions：16% PEG 6K, 0.01 M NA CITRATE Resolution 6.00 Å R-free 0.359
2 Protein heterocomplex Heteromer Protein × 12 PDB declaration: dodecameric（12） Consistent with protein copy count Chain H； UniProt 1–216 Chain J； UniProt 1–216 Chain N； UniProt 1–216 Chain R； UniProt 1–216 Mutation：YES PHOSPHATIDYLINOSITOL 4-KINASE BETA × 4 （Q9UBF8） RAB11 FAMILY-INTERACTING PROTEIN 3 × 4 （O75154） 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4 MG MAGNESIUM ION × 4 X-RAY DIFFRACTION X-ray crystallization conditions：16% PEG 6K, 0.01 M NA CITRATE Resolution 6.00 Å R-free 0.359
3 Protein heterocomplex Heteromer Protein × 12 PDB declaration: dodecameric（12） Consistent with protein copy count Chain X； UniProt 1–216 Chain Z； UniProt 1–216 Chain d； UniProt 1–216 Chain h； UniProt 1–216 Mutation：YES PHOSPHATIDYLINOSITOL 4-KINASE BETA × 4 （Q9UBF8） RAB11 FAMILY-INTERACTING PROTEIN 3 × 4 （O75154） 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4 MG MAGNESIUM ION × 4 X-RAY DIFFRACTION X-ray crystallization conditions：16% PEG 6K, 0.01 M NA CITRATE Resolution 6.00 Å R-free 0.359

Other States of the Same Protein in the Database

Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.

Other PDB Difference from Current Entry 4D0M Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Method and Experimental Conditions Structure Quality
1YZK GppNHp bound Rab11 GTPase Deposited 2005-02-28 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 8–175（168 aa）
Not recorded MG MAGNESIUM ION × 1 GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6；277 K；NaCl, Glycerol, MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 4K
Resolution 2.00 Å R-free 0.228
2D7C Crystal structure of human Rab11 in complex with FIP3 Rab-binding domain Deposited 2005-11-16 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain A 6–172（167 aa） Fragment：residues 7-173
Mutation：Q70L Non-standard monomer：Yes (specific site not provided by mmCIF) MG MAGNESIUM ION × 1 GTP GUANOSINE-5'-TRIPHOSPHATE × 1 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6；289 K；20% iso-propanol, 3% (w/v) PEG 4000, 0.05M MES-NaOH, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 1.75 Å R-free 0.224
2D7C Crystal structure of human Rab11 in complex with FIP3 Rab-binding domain Deposited 2005-11-16 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain B 6–172（167 aa） Fragment：residues 7-173
Mutation：Q70L Non-standard monomer：Yes (specific site not provided by mmCIF) MG MAGNESIUM ION × 1 GTP GUANOSINE-5'-TRIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6；289 K；20% iso-propanol, 3% (w/v) PEG 4000, 0.05M MES-NaOH, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 1.75 Å R-free 0.224
2GZD Crystal Structure of Rab11 in Complex with Rab11-FIP2 Deposited 2006-05-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain A 1–172（172 aa） Fragment：G protein domain
Chain B 1–172（172 aa） Fragment：G protein domain
Mutation：Q70L Non-standard monomer：Yes (specific site not provided by mmCIF) Mutation：Q70L Non-standard monomer：Yes (specific site not provided by mmCIF) MG MAGNESIUM ION × 2 GTP GUANOSINE-5'-TRIPHOSPHATE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION；pH 5；298 K；Ammonium phosphate buffer, between 0.1 and 0.5 M concentration, VAPOR DIFFUSION, temperature 298K
Resolution 2.44 Å R-free 0.279
2GZH Crystal Structure of Rab11 in Complex with Rab11-Family Interacting Protein 2 Deposited 2006-05-11 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain A 1–172（172 aa） Fragment：G protein domain
Mutation：Q70L Non-standard monomer：Yes (specific site not provided by mmCIF) PO4 PHOSPHATE ION × 2 MG MAGNESIUM ION × 4 GTP GUANOSINE-5'-TRIPHOSPHATE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION；pH 5；298 K；Ammonium phosphate buffer, approximately 0.3M concentration, pH 5, VAPOR DIFFUSION, temperature 298K
Resolution 2.47 Å R-free 0.254
2HV8 Crystal structure of GTP-bound Rab11 in complex with FIP3 Deposited 2006-07-27 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain A 5–174（170 aa） Fragment：GTPase domain
Mutation：Q70L MG MAGNESIUM ION × 2 SO4 SULFATE ION × 2 GTP GUANOSINE-5'-TRIPHOSPHATE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；277 K；20% PEG4000, 0.4M Ammonium Sulfate, 100mM MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 1.86 Å R-free 0.237
2HV8 Crystal structure of GTP-bound Rab11 in complex with FIP3 Deposited 2006-07-27 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain B 5–174（170 aa） Fragment：GTPase domain
Chain C 5–174（170 aa） Fragment：GTPase domain
Mutation：Q70L Mutation：Q70L MG MAGNESIUM ION × 2 SO4 SULFATE ION × 4 GTP GUANOSINE-5'-TRIPHOSPHATE × 2 2ME METHOXYETHANE × 1 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；277 K；20% PEG4000, 0.4M Ammonium Sulfate, 100mM MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 1.86 Å R-free 0.237
4C4P Crystal Structure of Wild-Type Rab11 Complexed to FIP2 Deposited 2013-09-07 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain A 1–173（173 aa） Fragment：RESIDUES 1-173
Not recorded GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.00 Å R-free 0.223
4D0L Phosphatidylinositol 4-kinase III beta-PIK93 in a complex with Rab11a- GTP gammaS Deposited 2014-04-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain B 1–216（216 aa）
Mutation：YES 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；15% (W/V) PEG 4000, 0.1 M NA CITRATE PH 5.6, AND 0.2 M AMMONIUM ACETATE
Resolution 2.94 Å R-free 0.259
4D0L Phosphatidylinositol 4-kinase III beta-PIK93 in a complex with Rab11a- GTP gammaS Deposited 2014-04-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain D 1–216（216 aa）
Mutation：YES 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；15% (W/V) PEG 4000, 0.1 M NA CITRATE PH 5.6, AND 0.2 M AMMONIUM ACETATE
Resolution 2.94 Å R-free 0.259
4D0L Phosphatidylinositol 4-kinase III beta-PIK93 in a complex with Rab11a- GTP gammaS Deposited 2014-04-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain F 1–216（216 aa）
Mutation：YES 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；15% (W/V) PEG 4000, 0.1 M NA CITRATE PH 5.6, AND 0.2 M AMMONIUM ACETATE
Resolution 2.94 Å R-free 0.259
4LWZ Crystal structure of Myo5b globular tail domain in complex with inactive Rab11a Deposited 2013-07-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain A 1–177（177 aa） Fragment：Dilute domain residues 1456-1848
Not recorded GDP GUANOSINE-5'-DIPHOSPHATE × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；298 K；17% peg, 100 mM NaCl, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.55 Å R-free 0.295
4LWZ Crystal structure of Myo5b globular tail domain in complex with inactive Rab11a Deposited 2013-07-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain C 1–177（177 aa） Fragment：Dilute domain residues 1456-1848
Not recorded GDP GUANOSINE-5'-DIPHOSPHATE × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；298 K；17% peg, 100 mM NaCl, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.55 Å R-free 0.295
4LX0 Crystal structure of Myo5b globular tail domain in complex with active Rab11a Deposited 2013-07-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain A 1–177（177 aa） Fragment：Dilute domain residues 1456-1848
Not recorded MG MAGNESIUM ION × 1 BEF BERYLLIUM TRIFLUORIDE ION × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；298 K；10 % peg, 90 mM NaF, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.19 Å R-free 0.218
4LX0 Crystal structure of Myo5b globular tail domain in complex with active Rab11a Deposited 2013-07-29 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain C 1–177（177 aa） Fragment：Dilute domain residues 1456-1848
Not recorded MG MAGNESIUM ION × 1 BEF BERYLLIUM TRIFLUORIDE ION × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；298 K；10 % peg, 90 mM NaF, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.19 Å R-free 0.218
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain A 4–186（183 aa） Fragment：GTPASE DOMAIN
Mutation：YES GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain D 4–186（183 aa） Fragment：GTPASE DOMAIN
Mutation：YES GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain G 4–186（183 aa） Fragment：GTPASE DOMAIN
Mutation：YES GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain J 4–186（183 aa） Fragment：GTPASE DOMAIN
Mutation：YES GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain M 4–186（183 aa） Fragment：GTPASE DOMAIN
Mutation：YES GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 6 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain P 4–186（183 aa） Fragment：GTPASE DOMAIN
Mutation：YES GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 7 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain S 4–186（183 aa） Fragment：GTPASE DOMAIN
Mutation：YES GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 8 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain V 4–186（183 aa） Fragment：GTPASE DOMAIN
Mutation：YES GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 PG4 TETRAETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ4 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric
Chain D 4–186（183 aa） Fragment：GTPASE DOMAIN, RESIDUES 4-186
Chain G 4–186（183 aa） Fragment：GTPASE DOMAIN, RESIDUES 4-186
Mutation：YES Mutation：YES GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2 MG MAGNESIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.8；50MM MES PH 5.8, 0.2M AMMONIUM SULFATE AND 14% PEG 8000
Resolution 4.20 Å R-free 0.266
4UJ4 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric
Chain A 4–186（183 aa） Fragment：GTPASE DOMAIN, RESIDUES 4-186
Chain J 4–186（183 aa） Fragment：GTPASE DOMAIN, RESIDUES 4-186
Mutation：YES Mutation：YES GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2 MG MAGNESIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.8；50MM MES PH 5.8, 0.2M AMMONIUM SULFATE AND 14% PEG 8000
Resolution 4.20 Å R-free 0.266
4UJ4 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric
Chain A 4–186（183 aa） Fragment：GTPASE DOMAIN, RESIDUES 4-186
Chain J 4–186（183 aa） Fragment：GTPASE DOMAIN, RESIDUES 4-186
Mutation：YES Mutation：YES GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2 MG MAGNESIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.8；50MM MES PH 5.8, 0.2M AMMONIUM SULFATE AND 14% PEG 8000
Resolution 4.20 Å R-free 0.266
4UJ5 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain A 6–186（181 aa） Fragment：GTPASE DOMAIN, RESIDUES 6-186
Mutation：YES GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；0.1M HEPES PH 7.0, 0.2M LITHIUM SULFATE AND 24% PEG 3350
Resolution 2.60 Å R-free 0.272
4UJ5 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain B 6–186（181 aa） Fragment：GTPASE DOMAIN, RESIDUES 6-186
Mutation：YES GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；0.1M HEPES PH 7.0, 0.2M LITHIUM SULFATE AND 24% PEG 3350
Resolution 2.60 Å R-free 0.272
5C46 Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta in complex with GTP gamma S loaded Rab11 Deposited 2015-06-17 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain F 1–216（216 aa）
Mutation：Q70L SO4 SULFATE ION × 2 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 5.6；290 K；PEG-4000, sodium citrate, ammonium sulfate, glycerol
Resolution 2.65 Å R-free 0.246
5C4G Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta with the inhibitor BQR695 in complex with GDP loaded Rab11 Deposited 2015-06-18 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain B 1–216（216 aa）
Mutation：Q70L MG MAGNESIUM ION × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 SO4 SULFATE ION × 2 BQR N~2~-[7-(3,4-dimethoxyphenyl)quinoxalin-2-yl]-N-methylglycinamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 5.6；290 K；PEG-4000, sodium citrate, ammonium sulfate, glycerol
Resolution 3.20 Å R-free 0.287
5EUQ Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta with a potent and selective inhibitor in complex with GDP loaded Rab11 Deposited 2015-11-19 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Insufficient information Heteromer；Protein × 2 PDB declaration: dimeric
Chain B 1–216（216 aa）
Not recorded GDP GUANOSINE-5'-DIPHOSPHATE × 1 SO4 SULFATE ION × 2 5S8 ~{N}-[5-[3-[[(4-hydroxyphenyl)amino]-bis(oxidanyl)-$l^{4}-sulfanyl]-4-methoxy-phenyl]-4-methyl-1,3-thiazol-2-yl]cyclopentanecarboxamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION；pH 5.6；290 K；PEG-4000, sodium citrate, ammonium sulfate, glycerol
Resolution 3.20 Å R-free 0.266
5EZ5 Crystal structure of active Rab11A (S20V) in complex with GTP Deposited 2015-11-26 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 8–175（168 aa） Fragment：UNP residues 8-175
Chain B 8–175（168 aa） Fragment：UNP residues 8-175
Mutation：S20V Mutation：S20V MG MAGNESIUM ION × 2 GTP GUANOSINE-5'-TRIPHOSPHATE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；293 K；Sodium chloride, Tris, Magnessium chloride
Resolution 2.40 Å R-free 0.304
5EZ5 Crystal structure of active Rab11A (S20V) in complex with GTP Deposited 2015-11-26 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 8–175（168 aa） Fragment：UNP residues 8-175
Chain B 8–175（168 aa） Fragment：UNP residues 8-175
Mutation：S20V Mutation：S20V MG MAGNESIUM ION × 2 GTP GUANOSINE-5'-TRIPHOSPHATE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；293 K；Sodium chloride, Tris, Magnessium chloride
Resolution 2.40 Å R-free 0.304
5FBL PI4KB in complex with Rab11 and the MI356 Inhibitor Deposited 2015-12-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain B 1–216（216 aa）
Not recorded 5W9 ~{N}-[2-[[6-chloranyl-3-(4-methoxy-3-morpholin-4-ylsulfonyl-phenyl)-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；291 K；1M Lithium chloride, 0.1M Citric acid pH=5, 10% (w/v) PEG 6000
Resolution 3.37 Å R-free 0.269
5FBQ PI4KB in complex with Rab11 and the MI358 Inhibitor Deposited 2015-12-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain B 1–216（216 aa）
Not recorded 5W6 ~{N}-[2-[[6-chloranyl-3-[3-[4-(hydroxymethyl)piperidin-1-yl]sulfonyl-4-methoxy-phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；291 K；0.2M magnesium chloride, 0.1M Tris PH=7, 10% (w/v) PEG 8000
Resolution 3.79 Å R-free 0.302
5FBR PI4KB in complex with Rab11 and the MI359 Inhibitor Deposited 2015-12-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain B 1–216（216 aa）
Not recorded 5W7 ~{N}-[2-[[3-[3-[(4-azanylcyclohexyl)sulfamoyl]-4-methoxy-phenyl]-6-chloranyl-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；291 K；0.15M amonium sulfate, 0.1M MES pH=6, 15% PEG 4000
Resolution 3.28 Å R-free 0.264
5FBV PI4KB in complex with Rab11 and the MI364 Inhibitor Deposited 2015-12-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain B 1–216（216 aa）
Not recorded 5W3 ~{N}-[2-[[6-chloranyl-3-[3-(2-hydroxyethylsulfamoyl)-4-methoxy-phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethy l]ethanamide × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；291 K；0.15M amonium sulfate, 0.1M MEW pH=6, 15% PEG 4000
Resolution 3.29 Å R-free 0.281
5FBW PI4KB in complex with Rab11 and the MI369 Inhibitor Deposited 2015-12-14 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain B 1–216（216 aa）
Not recorded 5W8 ~{N}-[2-[[6-chloranyl-3-[4-methoxy-3-[[(2~{R})-1-oxidanylbutan-2-yl]sulfamoyl]phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；291 K；0.2M ammonium sulfate, 0.1M MES pH=6.5, 20% (w/v) PEG 8000
Resolution 3.49 Å R-free 0.283
5JCZ Rab11 bound to MyoVa-GTD Deposited 2016-04-15 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain A 1–177（177 aa）
Not recorded MG MAGNESIUM ION × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 BEF BERYLLIUM TRIFLUORIDE ION × 1 EDO 1,2-ETHANEDIOL × 5 ACT ACETATE ION × 1 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；290 K；7% (w/v) PEG-8000, 50 mM Bicine, 50 mM Tris, 30mM sodium fluoride, 20% (v/v) ethylene glycol
Resolution 2.06 Å R-free 0.208
5JCZ Rab11 bound to MyoVa-GTD Deposited 2016-04-15 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain D 1–177（177 aa）
Not recorded MG MAGNESIUM ION × 2 GDP GUANOSINE-5'-DIPHOSPHATE × 1 BEF BERYLLIUM TRIFLUORIDE ION × 1 EDO 1,2-ETHANEDIOL × 6 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；290 K；7% (w/v) PEG-8000, 50 mM Bicine, 50 mM Tris, 30mM sodium fluoride, 20% (v/v) ethylene glycol
Resolution 2.06 Å R-free 0.208
5JCZ Rab11 bound to MyoVa-GTD Deposited 2016-04-15 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain I 1–177（177 aa）
Not recorded MG MAGNESIUM ION × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 BEF BERYLLIUM TRIFLUORIDE ION × 1 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；290 K；7% (w/v) PEG-8000, 50 mM Bicine, 50 mM Tris, 30mM sodium fluoride, 20% (v/v) ethylene glycol
Resolution 2.06 Å R-free 0.208
6DJL Crystal structure of the Rab11 GEF SH3BP5 bound to nucleotide free Rab11A Deposited 2018-05-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain A 1–216（216 aa）
Mutation：Q70L No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；289 K；23% PEG-3350, 200 mM NaCl, 100 mM Bis Tris pH-6.5
Resolution 3.10 Å R-free 0.278
6DJL Crystal structure of the Rab11 GEF SH3BP5 bound to nucleotide free Rab11A Deposited 2018-05-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain H 1–216（216 aa）
Mutation：Q70L No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；289 K；23% PEG-3350, 200 mM NaCl, 100 mM Bis Tris pH-6.5
Resolution 3.10 Å R-free 0.278
6DJL Crystal structure of the Rab11 GEF SH3BP5 bound to nucleotide free Rab11A Deposited 2018-05-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain G 1–216（216 aa）
Mutation：Q70L No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；289 K；23% PEG-3350, 200 mM NaCl, 100 mM Bis Tris pH-6.5
Resolution 3.10 Å R-free 0.278
6DJL Crystal structure of the Rab11 GEF SH3BP5 bound to nucleotide free Rab11A Deposited 2018-05-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain F 1–216（216 aa）
Mutation：Q70L No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；289 K；23% PEG-3350, 200 mM NaCl, 100 mM Bis Tris pH-6.5
Resolution 3.10 Å R-free 0.278
6IXV Crystal structure of SH3BP5-Rab11a Deposited 2018-12-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain E 1–173（173 aa）
Not recorded PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；293 K；0.6M NaCl, 0.1M NaH2PO4 pH 6.8, 16% PEG 2000
Resolution 3.80 Å R-free 0.259
6IXV Crystal structure of SH3BP5-Rab11a Deposited 2018-12-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain F 1–173（173 aa）
Not recorded PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；293 K；0.6M NaCl, 0.1M NaH2PO4 pH 6.8, 16% PEG 2000
Resolution 3.80 Å R-free 0.259
6IXV Crystal structure of SH3BP5-Rab11a Deposited 2018-12-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain G 1–173（173 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；293 K；0.6M NaCl, 0.1M NaH2PO4 pH 6.8, 16% PEG 2000
Resolution 3.80 Å R-free 0.259
6IXV Crystal structure of SH3BP5-Rab11a Deposited 2018-12-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain H 1–173（173 aa）
Not recorded PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；293 K；0.6M NaCl, 0.1M NaH2PO4 pH 6.8, 16% PEG 2000
Resolution 3.80 Å R-free 0.259
6IY1 Structure of human Ras-related protein Rab11 Deposited 2018-12-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 9–173（165 aa）
Not recorded GDP GUANOSINE-5'-DIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；293 K；0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4 1.2M Na2HPO4
Resolution 2.11 Å R-free 0.261
6IY1 Structure of human Ras-related protein Rab11 Deposited 2018-12-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 9–173（165 aa）
Not recorded GDP GUANOSINE-5'-DIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；293 K；0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4 1.2M Na2HPO4
Resolution 2.11 Å R-free 0.261
6IY1 Structure of human Ras-related protein Rab11 Deposited 2018-12-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain C 9–173（165 aa）
Not recorded GDP GUANOSINE-5'-DIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；293 K；0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4 1.2M Na2HPO4
Resolution 2.11 Å R-free 0.261
6IY1 Structure of human Ras-related protein Rab11 Deposited 2018-12-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain D 7–173（167 aa）
Not recorded GDP GUANOSINE-5'-DIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；293 K；0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4 1.2M Na2HPO4
Resolution 2.11 Å R-free 0.261
6IY1 Structure of human Ras-related protein Rab11 Deposited 2018-12-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain E 9–173（165 aa）
Not recorded GDP GUANOSINE-5'-DIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；293 K；0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4 1.2M Na2HPO4
Resolution 2.11 Å R-free 0.261
6IY1 Structure of human Ras-related protein Rab11 Deposited 2018-12-12 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 6 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain F 6–173（168 aa）
Not recorded GDP GUANOSINE-5'-DIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；293 K；0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4 1.2M Na2HPO4
Resolution 2.11 Å R-free 0.261
8VOF GI targeted CpPI4K inhibitor Deposited 2024-01-15 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain B 1–216（216 aa）
Mutation：Q70L A1ADE methyl 2-chloro-5-(methyl{(8R)-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carbonyl}amino)benzoate × 1 SO4 SULFATE ION × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；294 K；0.5M ammonium sulfate, 0.088M sodium citrate, 0.875M lithium sulfate, 2.4% glycerol, 2.5% ethylene glycol, 50mM HEPES pH 6.8
Resolution 3.00 Å R-free 0.270

26 other PDB entries and 56 assemblies. Open the comparison page and filter oligomeric states

View Construct and Data Evidence
UniProt name RB11A_HUMAN
Isoform —
PDB entities 2
Chains and sequence ranges Author chain B； PDBConstruct 4–219； UniProt 1–216 Author chain D； PDBConstruct 4–219； UniProt 1–216 Author chain H； PDBConstruct 4–219； UniProt 1–216 Author chain J； PDBConstruct 4–219； UniProt 1–216 Author chain N； PDBConstruct 4–219； UniProt 1–216 Author chain P； PDBConstruct 4–219； UniProt 1–216 Author chain R； PDBConstruct 4–219； UniProt 1–216 Author chain T； PDBConstruct 4–219； UniProt 1–216 Author chain X； PDBConstruct 4–219； UniProt 1–216 Author chain Z； PDBConstruct 4–219； UniProt 1–216 Author chain d； PDBConstruct 4–219； UniProt 1–216 Author chain h； PDBConstruct 4–219； UniProt 1–216

RAB11 FAMILY-INTERACTING PROTEIN 3

HOMO SAPIENS

UniProt O75154

State in the Current Structure

Assembly Oligomeric State Construct Mutations and Modifications Ligands, Ions and Associated Components Method and Experimental Conditions Structure Quality
1 Protein heterocomplex Heteromer Protein × 12 PDB declaration: dodecameric（12） Consistent with protein copy count Chain E； UniProt 713–756 Chain F； UniProt 713–756 Chain U； UniProt 713–756 Chain V； UniProt 713–756 Fragment：RAB-BINDING DOMAIN Mutation：YES PHOSPHATIDYLINOSITOL 4-KINASE BETA × 4 （Q9UBF8） RAS-RELATED PROTEIN RAB-11A × 4 （P62491） 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4 MG MAGNESIUM ION × 4 X-RAY DIFFRACTION X-ray crystallization conditions：16% PEG 6K, 0.01 M NA CITRATE Resolution 6.00 Å R-free 0.359
2 Protein heterocomplex Heteromer Protein × 12 PDB declaration: dodecameric（12） Consistent with protein copy count Chain K； UniProt 713–756 Chain L； UniProt 713–756 Chain e； UniProt 713–756 Chain f； UniProt 713–756 Fragment：RAB-BINDING DOMAIN Mutation：YES PHOSPHATIDYLINOSITOL 4-KINASE BETA × 4 （Q9UBF8） RAS-RELATED PROTEIN RAB-11A × 4 （P62491） 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4 MG MAGNESIUM ION × 4 X-RAY DIFFRACTION X-ray crystallization conditions：16% PEG 6K, 0.01 M NA CITRATE Resolution 6.00 Å R-free 0.359
3 Protein heterocomplex Heteromer Protein × 12 PDB declaration: dodecameric（12） Consistent with protein copy count Chain a； UniProt 713–756 Chain b； UniProt 713–756 Chain i； UniProt 713–756 Chain j； UniProt 713–756 Fragment：RAB-BINDING DOMAIN Mutation：YES PHOSPHATIDYLINOSITOL 4-KINASE BETA × 4 （Q9UBF8） RAS-RELATED PROTEIN RAB-11A × 4 （P62491） 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4 MG MAGNESIUM ION × 4 X-RAY DIFFRACTION X-ray crystallization conditions：16% PEG 6K, 0.01 M NA CITRATE Resolution 6.00 Å R-free 0.359

Other States of the Same Protein in the Database

Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.

Other PDB Difference from Current Entry 4D0M Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Method and Experimental Conditions Structure Quality
2D7C Crystal structure of human Rab11 in complex with FIP3 Rab-binding domain Deposited 2005-11-16 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain C 715–756（42 aa） Fragment：Rab-binding domain
Non-standard monomer：Yes (specific site not provided by mmCIF) MG MAGNESIUM ION × 1 GTP GUANOSINE-5'-TRIPHOSPHATE × 1 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6；289 K；20% iso-propanol, 3% (w/v) PEG 4000, 0.05M MES-NaOH, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 1.75 Å R-free 0.224
2D7C Crystal structure of human Rab11 in complex with FIP3 Rab-binding domain Deposited 2005-11-16 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric
Chain D 715–756（42 aa） Fragment：Rab-binding domain
Non-standard monomer：Yes (specific site not provided by mmCIF) MG MAGNESIUM ION × 1 GTP GUANOSINE-5'-TRIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6；289 K；20% iso-propanol, 3% (w/v) PEG 4000, 0.05M MES-NaOH, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 1.75 Å R-free 0.224
2HV8 Crystal structure of GTP-bound Rab11 in complex with FIP3 Deposited 2006-07-27 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain D 695–756（62 aa） Fragment：C-terminal region
Not recorded MG MAGNESIUM ION × 2 SO4 SULFATE ION × 2 GTP GUANOSINE-5'-TRIPHOSPHATE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；277 K；20% PEG4000, 0.4M Ammonium Sulfate, 100mM MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 1.86 Å R-free 0.237
2HV8 Crystal structure of GTP-bound Rab11 in complex with FIP3 Deposited 2006-07-27 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 4 PDB declaration: tetrameric
Chain E 695–756（62 aa） Fragment：C-terminal region
Chain F 695–756（62 aa） Fragment：C-terminal region
Not recorded MG MAGNESIUM ION × 2 SO4 SULFATE ION × 4 GTP GUANOSINE-5'-TRIPHOSPHATE × 2 2ME METHOXYETHANE × 1 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；277 K；20% PEG4000, 0.4M Ammonium Sulfate, 100mM MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 1.86 Å R-free 0.237
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain C 695–756（62 aa） Fragment：C-TERMINAL DOMAIN
Not recorded GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain F 695–756（62 aa） Fragment：C-TERMINAL DOMAIN
Not recorded GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain I 695–756（62 aa） Fragment：C-TERMINAL DOMAIN
Not recorded GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain L 695–756（62 aa） Fragment：C-TERMINAL DOMAIN
Not recorded GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain O 695–756（62 aa） Fragment：C-TERMINAL DOMAIN
Not recorded GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 6 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain R 695–756（62 aa） Fragment：C-TERMINAL DOMAIN
Not recorded GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 7 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain U 695–756（62 aa） Fragment：C-TERMINAL DOMAIN
Not recorded GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 8 Protein heterocomplex Heteromer；Protein × 3 PDB declaration: trimeric
Chain X 695–756（62 aa） Fragment：C-TERMINAL DOMAIN
Not recorded GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 PG4 TETRAETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
Resolution 3.00 Å R-free 0.250
4UJ4 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric
Chain F 695–756（62 aa） Fragment：C-TERMINAL DOMAIN, RESIDUES 695-756
Chain I 695–756（62 aa） Fragment：C-TERMINAL DOMAIN, RESIDUES 695-756
Not recorded GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2 MG MAGNESIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.8；50MM MES PH 5.8, 0.2M AMMONIUM SULFATE AND 14% PEG 8000
Resolution 4.20 Å R-free 0.266
4UJ4 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric
Chain C 695–756（62 aa） Fragment：C-TERMINAL DOMAIN, RESIDUES 695-756
Chain L 695–756（62 aa） Fragment：C-TERMINAL DOMAIN, RESIDUES 695-756
Not recorded GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2 MG MAGNESIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.8；50MM MES PH 5.8, 0.2M AMMONIUM SULFATE AND 14% PEG 8000
Resolution 4.20 Å R-free 0.266
4UJ4 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric
Chain C 695–756（62 aa） Fragment：C-TERMINAL DOMAIN, RESIDUES 695-756
Chain L 695–756（62 aa） Fragment：C-TERMINAL DOMAIN, RESIDUES 695-756
Not recorded GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2 MG MAGNESIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.8；50MM MES PH 5.8, 0.2M AMMONIUM SULFATE AND 14% PEG 8000
Resolution 4.20 Å R-free 0.266

4 other PDB entries and 15 assemblies. Open the comparison page and filter oligomeric states

View Construct and Data Evidence
UniProt name RFIP3_HUMAN
Isoform —
PDB entities 3
Chains and sequence ranges Author chain E； PDBConstruct 5–48； UniProt 713–756 Author chain F； PDBConstruct 5–48； UniProt 713–756 Author chain K； PDBConstruct 5–48； UniProt 713–756 Author chain L； PDBConstruct 5–48； UniProt 713–756 Author chain U； PDBConstruct 5–48； UniProt 713–756 Author chain V； PDBConstruct 5–48； UniProt 713–756 Author chain a； PDBConstruct 5–48； UniProt 713–756 Author chain b； PDBConstruct 5–48； UniProt 713–756 Author chain e； PDBConstruct 5–48； UniProt 713–756 Author chain f； PDBConstruct 5–48； UniProt 713–756 Author chain i； PDBConstruct 5–48； UniProt 713–756 Author chain j； PDBConstruct 5–48； UniProt 713–756

The page prioritizes protein identity, the current assembly, associated components, oligomeric state and cross-PDB links. Chain mapping and sequence ranges are retained as data evidence. Internal IDs, import timestamps and assembly operation expressions are maintenance fields and are not shown here.

SAXS scattering curve SAXS Profile

SAXS profile for 4d0m

P(r) Distance Distribution P(r) Distribution

P(r) distribution for 4d0m
Download Download
▼

2. Structure Basics 2. Structure Basics

Entry ID entry_id4d0m
Deposition date deposition_date2014-04-29
Structure title titlePhosphatidylinositol 4-kinase III beta in a complex with Rab11a-GTP- gamma-S and the Rab-binding domain of FIP3
Keywords keywords;PHOSPHOINOSITIDE, PHOSPHATIDYLINOSITOL 4-KINASE, LIPID KINASE, FAMILY OF RAB INTERACTING PROTEINS, FIP3, RAB-BINDING DOMAIN, RBD, RAB11, GTP, PIK93, GOLGI, RECYCLING ENDOSOME, SIGNALING PROTEIN ;; SIGNALING PROTEIN
Experimental Method methodX-RAY DIFFRACTION
▼

3. SAXS Parameters (CRYSOL theoretical calculation) 3. SAXS Parameters (CRYSOL)

Radius of gyration Rg (Guinier) rg_guinier84.85 Å
Radius of gyration Rg (electron density) rg_electron84.56 Å
Forward intensity I(0) i024067000000.00
Molecular weight molecular_weight871670.0 kDa
Excluded volume excluded_volume842170 ų
Envelope volume envelope_volume1987500 ų
Hydration-shell volume shell_volume192660 ų
Envelope diameter envelope_diameter273.4 Å
Shell Rg shell_rg88.19 Å
Envelope Rg envelope_rg80.11 Å
Shape Rg shape_rg84.57 Å
Total Rg total_rg84.55 Å
Total atoms total_atoms65970
Residues n_residues8154
Spherical-harmonic order n_harmonics20
q range q_range— – 0.5000 Å−1
Data points n_points101
Shell type shell_typedirectional
Solvent electron density solvent_density0.3340 e/ų
Shell contrast contrast_shell0.0300 e/ų
CRYSOL version crysol_version4.1.3
▼

4. P(r) Distance Distribution (GNOM inversion) 4. P(r) Analysis (GNOM)

Maximum dimension Dmax dmax206.1 Å
Rg (real space) rg_real82.21 Å
Rg uncertainty (real space) rg_real_error0.41 Å
I(0) (real space) i0_real2.3110e+10
I(0) uncertainty (real space) i0_real_error3.2630e+08
Rg (reciprocal space) rg_reciprocal85.33 Å
I(0) (reciprocal space) i0_reciprocal24100000000.0000
Solution quality estimate total_estimate0.6304
Solution quality rating solution_quality REASONABLE a REASONABLE solution
P(r) peaks n_peaks2
Primary peak position r_peak_primary137.4 Å
Skewness Skewness skewness-0.020
Kurtosis Kurtosis kurtosis-0.950
Angular range angular_range— – 0.0900 Å−1
Current regularization parameter α current_alpha0.6654
Highest regularization parameter α highest_alpha1823000000.0000
Real-space data points n_real_points19
GNOM version gnom_version4.1.3
Quality Criteria quality_criteria AN1: 0.000; Oscil: 0.999; Stabil: 0.970; Sysdev: 0.000; Positv: 1.000; Valcen: 0.309; Smooth: 0.000
▶

5. Crystallography and Experiment 5. Crystallography & Experiment

▶

6. Entities and Polymers Entities & Polymers (6)

▶

8. Citations (1)

▶

9. Files and Curves (10)